47 completed, 7 terminated, 6 unknown, 3 recruiting. 68 Phase 2, 11 Phase 1, 9 Phase 3.
Follow Patient Compliance: new trials by email Literature Review of Patient Compliance trials Research Report on Patient Compliance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation Varenicline (VAR), Nicotine lozenge (NRT), Smartphone intervention with adherence components (COMBO-A) - Smoking Cessation | Phase 2 | Recruiting | University of Oklahoma | 496 | 2026-07-21 | 2026-11-09 |
| An Integrated Intervention Using a Pill Ingestible Sensor System ISS-SBDOH arm - HIV/AIDS, Medication Adherence | Phase 2 | Recruiting | University of California, Los Angeles | 110 | 2024-12-19 | 2026-02-13 |
| Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial Cognitive Training - Mild Cognitive Impairment (MCI), Cognitive Training | Phase 2 | Recruiting | Columbia University | 240 | 2024-12-17 | 2026-07-28 |
| Preventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video Observation HiDO-ALZ - Alzheimer Disease, Dementia | Phase 2 | Completed | HiDO Technologies | 50 | 2024-09-05 | 2026-10-07 |
| Heart Failure Polypill at a Safety Net Hospital Heart failure polypill, Control Rx - Heart Failure With Reduced Ejection Fraction, HIV Infections | Phase 2 | Completed | University of California, San Francisco | 35 | 2024-02-27 | 2025-12-31 |
| Project Engage: Oral PrEP Acceptability emtricitabine/tenofovir alafenamide, Emtricitabine / Tenofovir Disoproxil Oral Tablet - Acceptability of Health Care, Adherence, Medication | Phase 2 | Completed | Eastern Virginia Medical School | 330 | 2022-06-21 | 2024-07-29 |
| Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers Maintenance ICS and Symptom Driven SABA, Symptom-driven budesonide/formoterol combination - Asthma in Children, Nonadherence, Medication | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 55 | 2022-04-01 | 2026-08-19 |
| Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA - Asthma, Nonadherence, Medication | Phase 1 / Phase 2 | Active not recruiting | Washington University School of Medicine | 60 | 2021-12-16 | 2026-08-19 |
| The Role of TCM on ERAS of Rectal Cancer Patients acupoint with TCM, acupoint with placebo - Rectal Cancer | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 264 | 2020-09-28 | 2021-02-11 |
| Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors Motivational enhancement therapy, Attention Control - Breast Cancer, Medication Adherence | Phase 2 / Phase 3 | Withdrawn | University of Calgary | 2020-08-01 | 2024-12-05 | |
| Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention Vaginal Renewal Program - Adherence, Medication | Phase 2 | Terminated | University of Wisconsin, Madison | 2 | 2019-11-19 | 2021-10-20 |
| Medication Responsiveness in Parkinson's Disease CloudUPDRS - Tapping Task - Parkinson Disease, Medication Compliance | Phase 2 | Completed | KU Leuven | 33 | 2019-07-25 | 2021-01-27 |
| Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment Polycap - Atherosclerosis, Adherence, Medication | Phase 2 | Completed | Northern California Institute of Research and Education | 148 | 2019-02-14 | 2023-12-20 |
| A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement Levocarnitine - Patient Compliance | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 104 | 2018-04-17 | 2019-10-30 |
| Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 150 | 2018-02-02 | 2021-05-18 |
| Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen Envarsus - Heart Transplant Rejection, Graft Failure | Phase 2 | Completed | Baylor Research Institute | 50 | 2017-12-04 | 2025-10-08 |
| Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 26 | 2015-11-02 | 2020-03-10 |
| Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload Deferasirox granule formulation, Deferasirox DT formulation - Transfusion-dependent Anemia | Phase 2 | Completed | Novartis Pharmaceuticals | 224 | 2015-10-21 | 2024-09-19 |
| Emtricitabine/Tenofovir Alafenamide as Salvage ART FTC/TAF - HIV | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 1 | 2015-09-16 | 2017-11-14 |
| Directly Observed Therapy for HCV in Chennai, India Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin - Hepatitis C, Chronic | Phase 2 | Completed | Johns Hopkins Bloomberg School of Public Health | 50 | 2015-09-01 | 2021-04-15 |
Showing 20 of 68. Sign in to see all of them.
Medication Adherence (21) · Health Education (14) · Directly Observed Therapy (7) · HIV Infections (6) · Motor Activity (5) · Acquired Immunodeficiency Syndrome (4) · Alcoholism (4) · Asthma (3) · Breast Neoplasms (3) · Diabetes Mellitus (3) · Hyperlipidemias (3) · Atherosclerosis (2) · Behavior (2) · Cardiovascular Diseases (2)
Health Behavior (68) · Treatment Adherence and Compliance (68) · Patient Acceptance of Health Care (67) · Behavior (66) · Medication Adherence (22) · Adherence Interventions (14) · Immune System Diseases (12) · Infections (11) · Mental Disorders (11) · Metabolic Diseases (11) · Nutritional and Metabolic Diseases (11) · Blood-Borne Infections (10) · Communicable Diseases (10) · RNA Virus Infections (10)
Exercise (4) · Emtricitabine (2) · Motivational Interviewing (2) · Sofosbuvir (2) · Tobacco Use Cessation Devices (2) · peginterferon alfa-2a (2) · Acetazolamide (1) · Acupuncture Points (1) · Alprazolam (1) · Carbon Monoxide (1) · Carnitine (1) · Citalopram (1) · Cognitive Training (1) · Contracts (1) · Counseling (1)
Butler Hospital (2) · Georgetown University (2) · Johns Hopkins Bloomberg School of Public Health (2) · Kovacs Foundation (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Novartis Pharmaceuticals (2) · San Diego State University (2) · US Department of Veterans Affairs (2) · University of California, San Francisco (2) · VA Office of Research and Development (2) · Washington University School of Medicine (2) · Yale University (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Baylor Research Institute (1)
United States (44) · Canada (4) · India (3) · South Africa (3) · Belgium (2) · China (2) · France (2) · Iran (2) · Spain (2) · Bangladesh (1) · Bulgaria (1) · Denmark (1) · Egypt (1) · Ghana (1) · Hungary (1)
Carl J Stepnowsky, PhD (2) · Christina D Adams, PhD (2) · Ahmad Shavakhi, M.D. (1) · Aiwen Wu, M.D. (1) · Akram Pourshams, PhD (1) · Alexander Dromerick, MD (1) · Alice Nieuwboer (1) · Alice Pau, Pharm.D. (1) · Ana Abrantes, PhD (1) · Antonio Ruiz, MD (1) · Ashley J Beard, PhD (1) · Carlos Isanta, MD (1) · Celia Albaladejo, MD (1)
PMID 11764222, PMID 11852377, PMID 12037511, PMID 12448827, PMID 12746623, PMID 12846028, PMID 16818482, PMID 17441783, PMID 17513285, PMID 19122865, PMID 19255065, PMID 19597072, PMID 19928484, PMID 20105415, PMID 20147875, PMID 20192725, PMID 20453627, PMID 20598843, PMID 21443297, PMID 23122489, PMID 23186301, PMID 23248342, PMID 23688320, PMID 23816039, PMID 23823651, PMID 24212451, PMID 24977401, PMID 25890676, PMID 25909320, PMID 26631085, PMID 26908586, PMID 27347650, PMID 27590273, PMID 27837101, PMID 28719029, PMID 29065955, PMID 29540234, PMID 30633744, PMID 31141465, PMID 32072434, PMID 32421208, PMID 34433608, PMID 36471430, PMID 36602886, PMID 37268772, PMID 37734804, PMID 38588457, PMID 39082406, PMID 39208136, PMID 40118491
KL2TR002346 (2), R01DA026727 (2), UL1TR002345 (2), K01CA160670 (1), K23DA019950 (1), P60AR036308 (1), R01AA013957 (1), R01AA018923 (1), R01AG052440 (1), R01AI055359 (1), R01AR044020 (1), R01CA298165 (1), R01DK072325 (1), R01MD019188 (1), R01MH063011 (1)